{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:49:59Z","timestamp":1792068599856,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.diagmicrobio.2026.117608","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:48:12Z","timestamp":1786171692000},"page":"117608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parvovirus B19 serological states and antinuclear antibody positivity: A comparative clinical virology study including EBV and CMV DNAemia"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-0803","authenticated-orcid":false,"given":"Emrah","family":"Salman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8303-901X","authenticated-orcid":false,"given":"Sibel","family":"G\u00f6kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117608_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117608_bib0002","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/microorganisms12081708","article-title":"Parvovirus B19 in rheumatic diseases","volume":"12","author":"Arvia","year":"2024","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117608_bib0003","article-title":"High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease","volume":"8","author":"D\u2019Onofrio","year":"2024","journal-title":"Rheumatol Adv Pr"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117608_bib0004","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrrheum.2017.74","article-title":"Antinuclear antibody testing - misunderstood or misbegotten?","volume":"13","author":"Pisetsky","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117608_bib0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/art.41214","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"72","author":"Dinse","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117608_bib0006","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117608_bib0007","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni911","article-title":"Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections","volume":"4","author":"Hunziker","year":"2003","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117608_bib0008","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1189\/jlb.0407214","article-title":"Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host?","volume":"82","author":"Montes","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117608_bib0009","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1084\/jem.181.4.1557","article-title":"Novel packages of viral and self-antigens are generated during apoptosis","volume":"181","author":"Rosen","year":"1995","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117608_bib0010","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/microorganisms8121875","article-title":"Epstein-Barr Virus reactivation-induced immunoglobulin production: significance on autoimmunity","volume":"8","author":"Nagata","year":"2020","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117608_bib0011","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"issue":"47","key":"10.1016\/j.diagmicrobio.2026.117608_bib0012","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.15585\/mmwr.mm7347a2","article-title":"Detection of increased activity of Human parvovirus B19 using commercial laboratory testing of clinical samples and source plasma donor pools - United States, 2024","volume":"73","author":"Alfego","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117608_bib0013","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/S1473-3099(24)00373-6","article-title":"Extreme upsurge of parvovirus B19 resulting in severe fetal morbidity and mortality","volume":"24","author":"Russcher","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113960","article-title":"Clinical implications of human Parvovirus B19 infection on autoimmunity and autoimmune diseases","volume":"147","author":"Tzang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0015","article-title":"Prevalence, cell tropism, and clinical impact of Human parvovirus persistence in adenomatous, cancerous, inflamed, and healthy intestinal mucosa","volume":"13","author":"Xu","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117608_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-4453(96)80008-9","article-title":"Autoantibodies following parvovirus B19 infection","volume":"32","author":"Kerr","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.623944","article-title":"Epstein Barr virus and autoimmune responses in systemic Lupus Erythematosus","volume":"11","author":"Jog","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117608_bib0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/v13020277","article-title":"Viral infections and systemic lupus erythematosus: new players in an old story","volume":"13","author":"Quaglia","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117608_bib0019","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein-Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117608_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12985-021-01674-1","article-title":"Modulation of host cell signaling during cytomegalovirus latency and reactivation","volume":"18","author":"Smith","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2014.06.017","article-title":"Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process","volume":"190","author":"Adamson-Small","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcv.2016.09.004","article-title":"Detection of parvovirus B19 DNA in blood: viruses or DNA remnants?","volume":"84","author":"Molenaar-de Backer","year":"2016","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117608_bib0023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/v14040843","article-title":"Evaluation of molecular test for the discrimination of \u201cnaked\u201d DNA from infectious parvovirus B19 particles in serum and bone marrow samples","volume":"14","author":"Alves","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117608_bib0024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1568-9972(03)00014-4","article-title":"Parvovirus B19 infection and autoimmune disease","volume":"2","author":"Lehmann","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"20","key":"10.1016\/j.diagmicrobio.2026.117608_bib0025","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0026","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2015.09.007","article-title":"Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses","volume":"72","author":"Page","year":"2015","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117608_bib0027","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/21505594.2017.1385691","article-title":"Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome","volume":"9","author":"Lin","year":"2018","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117608_bib0028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000232945","article-title":"Human parvovirus B19 (B19V) infection in systemic sclerosis patients","volume":"52","author":"Zakrzewska","year":"2009","journal-title":"Intervirology"},{"key":"10.1016\/j.diagmicrobio.2026.117608_bib0029","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","article-title":"Type I interferons in autoimmune disease","volume":"14","author":"Crow","year":"2019","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117608_bib0030","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/ijms23052505","article-title":"Type I interferons in systemic Lupus erythematosus: a journey from bench to bedside","volume":"23","author":"Sim","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117608_bib0031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13287-018-0811-7","article-title":"High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow","volume":"9","author":"Watanabe","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117608_bib0032","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.59.5.342","article-title":"Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis","volume":"59","author":"Stahl","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117608_bib0033","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CMR.00040-16","article-title":"Human parvoviruses","volume":"30","author":"Qiu","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"Pt 6","key":"10.1016\/j.diagmicrobio.2026.117608_bib0034","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1099\/jmm.0.05485-0","article-title":"Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19","volume":"53","author":"Corcoran","year":"2004","journal-title":"J Med Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326003585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326003585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:09:58Z","timestamp":1792066198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326003585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0732889326003585"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117608","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parvovirus B19 serological states and antinuclear antibody positivity: A comparative clinical virology study including EBV and CMV DNAemia","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117608"}}